743 INCLINE-101: preliminary safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TAC-001 (TLR9 agonist conjugated to a CD22 mAb) in patients with advanced or metastatic solid tumors

oleh: Joshua Lee, Anna Pavlick, Feng Jin, Cesar Perez, Martin Gutierrez, Anthony El-Khoueiry, Ons Harrabi, Jason Henry, Sunnie Kim, Sangeetha Bollini, Kevin N Heller, Timothy Humphries

Format: Article
Diterbitkan: BMJ Publishing Group 2023-11-01

Deskripsi

No description available for this item.